Cassava Sciences, Inc. (SAVA) earnings

SAVA earnings moved a median of +1.36% by the close. Quarterly and annual SAVA reports and results, each read against the price at its own news timestamp. Back to the SAVA overview →

14 measured SAVA earnings events.

Where these SAVA earnings landedvs 10 measured SAVA earnings reactions
SAVA earningsMiddle 50% · +0.16% to +7.03%Zero: 0.00%Median: +1.36%Median +1.36%-10.00%0+10.00%
Middle 50% of SAVA earnings reactions+0.16% to +7.03%
Median reaction (to close)+1.36%
Measured reactions10
Point-in-time · zero look-ahead

Half of the 10 SAVA earnings events with a measured close landed between +0.16% and +7.03%; 80% closed up.

DateHeadlineEvent5-minTo close
Form 10-Q FILANA THERAPEUTICS, For: Jun 30SEC filing · Form 10-Q——
Form 10-Q FILANA THERAPEUTICS, For: Mar 31SEC filing · Form 10-Q——
Form 10-K FILANA THERAPEUTICS, For: Dec 31SEC filing · Form 10-K——
Form 10-Q CASSAVA SCIENCES INC For: Sep 30SEC filing · Form 10-Q-1.60%—
Form 10-Q CASSAVA SCIENCES INC For: Jun 30SEC filing · Form 10-Q+5.23%+9.54%
Form 10-Q CASSAVA SCIENCES INC For: Mar 31SEC filing · Form 10-Q+2.66%+4.73%
Form 10-K CASSAVA SCIENCES INC For: Dec 31SEC filing · Form 10-K-1.26%+9.39%
Form 10-Q CASSAVA SCIENCES INC For: Sep 30SEC filing · Form 10-Q+1.52%+7.80%
Cassava Sciences to Report Third Quarter 2024 Results on November 7, 2024Press release-0.76%+0.02%
Form 10-Q CASSAVA SCIENCES INC For: Jun 30SEC filing · Form 10-Q+4.57%-13.67%
Form 10-Q CASSAVA SCIENCES INC For: Mar 31SEC filing · Form 10-Q-1.18%+0.58%
Form 10-K CASSAVA SCIENCES INC For: Dec 31SEC filing · Form 10-K+0.09%-1.20%
Cassava Sciences Reports Third Quarter 2023 Financial and Operating ResultsPress release-1.02%+1.36%
Form 10-Q CASSAVA SCIENCES INC For: Sep 30SEC filing · Form 10-Q-1.02%+1.36%
That’s how SAVA usually reacts to earnings — get an email when it moves on news →
Keep exploring

More SAVA: analyst actions → · SEC filings → · SAVA overview →